Tokenised stocks on the X Layer blockchain, linked to the OKX exchange, added $32 million in market capitalization over a week, marking significant growth since their launch in June 2026. Despite this, the OKB token, used to pay transaction fees on X Layer, saw a 4.19% price decline over the same period. The key investor considerations include understanding that stock tokens are financial instruments regulated under MiFID II, not the crypto-focused MiCA, affecting licensing and taxation. Unlike crypto assets, gains on stock tokens may be taxed immediately without a one-year holding exemption. Additionally, these tokens provide price exposure without shareholder rights, and custody risks differ from owning actual shares. The ongoing SEC review of a joint venture to enable 24/7 trading of 63 tokenised US stocks adds further uncertainty to the market's regulatory landscape.
OKB token and X Layer stock tokens provide context for Pluang's market snapshot as of Oct 29, 2026 09:21 WIB. Among 50 major cryptocurrencies, 9 rose and 40 fell today. Notable movers include BAL at Rp16.297 with +11.14% change, EOS at Rp12.649 with +8.13%, and KSM at Rp66.070 with -5.06% and 87% sell order activity.
The global music market is projected to grow from $36.13 billion in 2026 to $57.74 billion by 2032, at a CAGR of 8.07%, fueled by paid streaming subscriptions, smartphone adoption, and digital music discovery. North America remains the largest market...
LUXEED held a global media test drive event at Chery's International Headquarters in Vu Hồ, featuring the luxury MPV LLounge and the high-performance Stormax SUV. Media representatives and influencers from UAE, Thailand, and Indonesia experienced a 1...
HUTCHMED announced that the US FDA has granted orphan drug designation to sovleplenib for treating primary immune thrombocytopenia (ITP), a rare autoimmune disorder causing low platelet counts and bleeding risks. This status provides benefits like 7 ...
China's coffee market is projected to grow from $5.8 billion in 2026 to $8.04 billion by 2032, at a CAGR of 5.54%. Growth is fueled by expanding chain cafes, specialty coffee methods like cold brew, and rising homegrown brands. However, rising coffee...
Nautilus Biotechnology (NAUT) is extending its Voyager platform from tau protein analysis into oncology, broadening its applications in targeted proteoform research. The company has ongoing research collaborations and participates in SEEDS, indicatin...
